Tachibana Hiroshi, Cheng Xun-Jia, Masuda Gohta, Horiki Noriyuki, Takeuchi Tsutomu
Department of Infectious Diseases, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
J Clin Microbiol. 2004 Mar;42(3):1069-74. doi: 10.1128/JCM.42.3.1069-1074.2004.
We have recently identified a 150-kDa surface antigen of Entamoeba histolytica as an intermediate subunit (Igl) of galactose- and N-acetyl-D-galactosamine-inhibitable lectin, which is a cysteine-rich protein consisting of 1,101 amino acids (aa) and containing multiple CXXC motifs in amino acid sequences. In the present study, full-length Igl except for the signal sequences (aa 14 to 1088) and three fragments of Igl-the N-terminal part (aa 14 to 382), the middle part (aa 294 to 753), and the C-terminal part (aa 603 to 1088)-were prepared in Escherichia coli, and the reactivity of these recombinant proteins with sera from patients with amebiasis was examined by means of enzyme-linked immunosorbent assay (ELISA). Sera from 57 symptomatic patients with amebic liver abscess or amebic colitis, sera from 15 asymptomatic cyst passers, sera from 40 individuals with other protozoan infections, and sera from 50 healthy controls were used. The sensitivity and specificity of the recombinant full-length Igl in the ELISA were 90 and 94%, respectively. When three fragments were used as antigens in the ELISA, the sensitivities were 56% in the N terminus, 92% in the middle part, and 97% in the C terminus. The specificities of the three antigens were 96% in the N terminus and 99% in both the middle and C-terminal fragments. These results demonstrate that Igl is well recognized in not only symptomatic but also asymptomatic patients with E. histolytica infection and that the carboxyl terminus of Igl is an especially useful antigen for the serodiagnosis of amebiasis.
我们最近鉴定出溶组织内阿米巴的一种150 kDa表面抗原为半乳糖和N-乙酰-D-半乳糖胺可抑制凝集素的中间亚基(Igl),它是一种富含半胱氨酸的蛋白质,由1101个氨基酸(aa)组成,氨基酸序列中含有多个CXXC基序。在本研究中,制备了去除信号序列(第14至1088位氨基酸)的全长Igl以及Igl的三个片段——N端部分(第14至382位氨基酸)、中间部分(第294至753位氨基酸)和C端部分(第603至1088位氨基酸),并通过酶联免疫吸附测定(ELISA)检测这些重组蛋白与阿米巴病患者血清的反应性。使用了57例有症状的阿米巴肝脓肿或阿米巴结肠炎患者的血清、15例无症状排包囊者的血清、40例其他原生动物感染个体的血清以及50例健康对照者的血清。重组全长Igl在ELISA中的敏感性和特异性分别为90%和94%。当将三个片段用作ELISA中的抗原时,N端的敏感性为56%,中间部分为92%,C端为97%。这三种抗原的特异性在N端为96%,在中间和C端片段均为99%。这些结果表明,Igl在溶组织内阿米巴感染的有症状和无症状患者中均能被很好地识别,并且Igl的羧基末端是阿米巴病血清诊断特别有用的抗原。